These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15004171)

  • 1. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.
    Gough PJ; Garton KJ; Wille PT; Rychlewski M; Dempsey PJ; Raines EW
    J Immunol; 2004 Mar; 172(6):3678-85. PubMed ID: 15004171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.
    Gutwein P; Abdel-Bakky MS; Doberstein K; Schramme A; Beckmann J; Schaefer L; Amann K; Doller A; Kämpfer-Kolb N; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
    J Cell Mol Med; 2009 Sep; 13(9B):3809-25. PubMed ID: 19426159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.
    Maretzky T; Reiss K; Ludwig A; Buchholz J; Scholz F; Proksch E; de Strooper B; Hartmann D; Saftig P
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9182-7. PubMed ID: 15958533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.
    Garbers C; Jänner N; Chalaris A; Moss ML; Floss DM; Meyer D; Koch-Nolte F; Rose-John S; Scheller J
    J Biol Chem; 2011 Apr; 286(17):14804-11. PubMed ID: 21454673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metalloproteinase ADAM10 requires its activity to sustain surface expression.
    Seifert A; Düsterhöft S; Wozniak J; Koo CZ; Tomlinson MG; Nuti E; Rossello A; Cuffaro D; Yildiz D; Ludwig A
    Cell Mol Life Sci; 2021 Jan; 78(2):715-732. PubMed ID: 32372373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1.
    Schwarz N; Pruessmeyer J; Hess FM; Dreymueller D; Pantaler E; Koelsch A; Windoffer R; Voss M; Sarabi A; Weber C; Sechi AS; Uhlig S; Ludwig A
    Cell Mol Life Sci; 2010 Dec; 67(24):4233-48. PubMed ID: 20559678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain shedding and autocleavage of the cardiac membrane protease corin.
    Jiang J; Wu S; Wang W; Chen S; Peng J; Zhang X; Wu Q
    J Biol Chem; 2011 Mar; 286(12):10066-72. PubMed ID: 21288900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease.
    Wang FT; Wu TQ; Lin Y; Jiao YR; Li JY; Ruan Y; Yin L; Chen CQ
    Int Immunopharmacol; 2024 May; 132():112015. PubMed ID: 38608478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis.
    Xiao W; Pinilla-Baquero A; Faulkner J; Song X; Prabhakar P; Qiu H; Moremen KW; Ludwig A; Dempsey PJ; Azadi P; Wang L
    Sci Rep; 2022 Mar; 12(1):4352. PubMed ID: 35288626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Disintegrin and metalloproteinase carves T cell abnormalities and pathogenesis in systemic lupus erythematosus.
    Umeda M; Satyam A; Yoshida N; Kawakami A
    Clin Immunol; 2024 May; 262():110168. PubMed ID: 38458301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific gene NSG1 binds to and positively regulates sortilin ectodomain shedding via a metalloproteinase-dependent mechanism.
    Overby M; Serrano-Rodriguez A; Dadras S; Christiansen AK; Ozcelik G; Lichtenthaler SF; Weick JP; Müller HK
    J Biol Chem; 2023 Dec; 299(12):105446. PubMed ID: 37949230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis.
    Drexhage LZ; Zhang S; Dupont M; Ragaller F; Sjule E; Cabezas-Caballero J; Deimel LP; Robertson H; Russell RA; Dushek O; Sezgin E; Karaji N; Sattentau QJ
    Nat Commun; 2024 Jan; 15(1):541. PubMed ID: 38225245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regarding the predictive role of CXCL16 in liver inflammation in chronic hepatitis B patients.
    Zhang J; Zhang Y
    J Viral Hepat; 2024 Sep; 31(9):573. PubMed ID: 38858786
    [No Abstract]   [Full Text] [Related]  

  • 14. ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing.
    Zocchi MR; Camodeca C; Nuti E; Rossello A; Venè R; Tosetti F; Dapino I; Costa D; Musso A; Poggi A
    Oncoimmunology; 2016 May; 5(5):e1123367. PubMed ID: 27467923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 release by ADAM metalloproteinase inhibitors.
    Ireland J; Segura J; Shi G; Buchwald J; Roth G; Shen TJ; Wang R; Ji X; Fischer ER; Moir S; Chun TW; Sun PD
    Front Microbiol; 2024; 15():1385775. PubMed ID: 38572241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Functional Variant of CXCL16 Is Associated With Predisposition to Sepsis and MODS in Trauma Patients: Genetic Association Studies.
    Sun J; Zhang H; Liu D; Cui L; Wang Q; Gan L; Wen D; Wang J; Du J; Huang H; Zhang A; Deng J; Jiang J; Zeng L
    Front Genet; 2021; 12():720313. PubMed ID: 34539750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL16/CXCR6 interaction promotes endometrial decidualization via the PI3K/AKT pathway.
    Mei J; Yan Y; Li SY; Zhou WJ; Zhang Q; Li MQ; Sun HX
    Reproduction; 2019 Mar; 157(3):273-282. PubMed ID: 30620718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer mapping of single CD8
    Tooley K; Jerby L; Escobar G; Krovi SH; Mangani D; Dandekar G; Cheng H; Madi A; Goldschmidt E; Lambden C; Krishnan RK; Rozenblatt-Rosen O; Regev A; Anderson AC
    Cell Rep Med; 2024 Jul; 5(7):101640. PubMed ID: 38959885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sCXCL16 as a prognostic biomarker for COVID-19 outcome.
    Boukhalfa Y; Stambouli N; Driss A; Daiki M; Abouda A; Razgallah R; Gharsallah H; Sellami W; Abid R; Hannachi S; Battikh R; Benmoussa M; Mazigh C; Ferjani M; Elgaaied AB; Labbene I
    J Med Virol; 2023 Apr; 95(4):e28728. PubMed ID: 37185869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
    Maas SL; Donners MMPC; van der Vorst EPC
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.